Polynucleotides encoding ketoreductases for producing stereoisomerically pure statins and synthetic intermediates therefor
US8617864B2 · kind B2 · utility
0Cited by
33References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2012 |
| Grant date | Dec 31, 2013 |
| Priority date | — |
| Expiry date | Aug 9, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12P7/62
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure provides ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, method of using the engineered ketoreductase enzymes to synthesize a variety of chirally pure compounds, and the chirally pure compounds prepared therewith.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.